Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis.

作者: Shoshana Yakar , Lothar Hennighausen , Derek LeRoith , Ling Zhao , Yiping Wu

DOI:

关键词: EndocrinologyInsulin-like growth factor-binding proteinMetastasisInsulin-like growth factorGrowth factorMedicineInternal medicineCecumColorectal cancerAdenocarcinomaLung cancer

摘要: It has been shown previously that slight elevations in serum levels of insulin-like growth factor-I (IGF-I) are correlated with an increased risk for developing prostate, breast, colon, and lung cancer. The aim this study was to determine the role IGF-I process stimulating tumor metastasis a mouse model colon Colon 38 adenocarcinoma tissue fragments were orthotopically transplanted by attachment surface cecum control liver-specific IGF-I-deficient (LID) mice which 25% mice. A total 156 male at 5 weeks age (74 82 LID mice) received transplants. Mice divided randomly into two groups; one group injected i.p. recombinant human (2 mg/kg) twice daily 6 weeks, other saline injections. treatment IGFBP-3 both In saline-injected group, incidence on as well frequency hepatic significantly higher compared Both treated displayed rates development liver, number metastatic nodules liver expression vascular epithelial factor (VEGF) vessel abundance tumors dependent IGF-I. This supports hypothesis circulating play important metastasis.

参考文章(35)
D. A. Sens, T. S. Gramling, M. G. Buse, R. Furlanetto, T. Gansler, N. Blocker, A. J. Garvin, K. A. Robinson, Antibody to type I insulinlike growth factor receptor inhibits growth of Wilms' tumor in culture and in athymic mice. American Journal of Pathology. ,vol. 135, pp. 961- 966 ,(1989)
Richard W. Furlanetto, Shari E. Harwell, Raymond B. Baggs, Effects of insulin-like growth factor receptor inhibition on human melanomas in culture and in athymic mice Cancer Research. ,vol. 53, pp. 2522- 2526 ,(1993)
Andrew A Butler, Vicky A Blakesley, Maria Tsokos, Vasiliki Pouliki, Teresa L Wood, Derek LeRoith, None, Stimulation of Tumor Growth by Recombinant Human Insulin-like Growth Factor-I (IGF-I) Is Dependent on the Dose and the Level of IGF-I Receptor Expression Cancer Research. ,vol. 58, pp. 3021- 3027 ,(1998)
Eleanor J. Manseau, Brygida Berse, Kathi Tognazzi, Donald R. Senger, Lawrence F. Brown, Harold F. Dvorak, Robert W. Jackman, Expression of Vascular Permeability Factor (Vascular Endothelial Growth Factor) and Its Receptors in Adenocarcinomas of the Gastrointestinal Tract Cancer Research. ,vol. 53, pp. 4727- 4735 ,(1993)
Marc R. Hammerman, Steven B. Miller, Effects of growth hormone and insulin-like growth factor I on renal growth and function The Journal of Pediatrics. ,vol. 131, ,(1997) , 10.1016/S0022-3476(97)70004-0
Napoleone Ferrara, Keith Houck, LYN Jakeman, David W Leung, None, Molecular and Biological Properties of the Vascular Endothelial Growth Factor Family of Proteins Endocrine Reviews. ,vol. 13, pp. 18- 32 ,(1992) , 10.1210/EDRV-13-1-18
J. L. Varga, A. V. Schally, V. J. Csernus, M. Zarandi, G. Halmos, K. Groot, Z. Rekasi, Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities Proceedings of the National Academy of Sciences of the United States of America. ,vol. 96, pp. 692- 697 ,(1999) , 10.1073/PNAS.96.2.692
Stephen E. Borst, David T. Lowenthal, Role of IGF-I in muscular atrophy of aging Endocrine. ,vol. 7, pp. 61- 63 ,(1997) , 10.1007/BF02778065
R.C. Jenkins, R.J.M. Ross, Growth hormone therapy for protein catabolism QJM: An International Journal of Medicine. ,vol. 89, pp. 813- 820 ,(1996) , 10.1093/QJMED/89.11.813